|
PROSTAGLANDINS:
A CALL TO ARMS
Prostaglandins
are infinitesimal, ephemeral, and powerful signaling molecules, self-
regulating every cell in the body, a structure or function not regulated by
prostaglandins yet to be discovered. Derived from essential fatty acids,
prostaglandins signal within the cell, from cell- to- cell, tissue- to- issue,
organ–to-organ, brain- to-body, and body to brain. When
prostaglandin metabolism is regulated, physiological processes function
normally; when up-regulated, physiology becomes pathology.
In 1930 Rafael Kurzrok and Charles Lieb noted that semen can,
paradoxically, cause uterine muscle to either relax or contract. In 1936, Ulf
von Euler and Maurice Goldblatt isolated the active principles from the semen
of boars, von Euler naming them "prostaglandins" out of the erroneous
belief that they are manufactured exclusively by the prostate. In 1960 Sunne
Bergstrom characterized the structure of prostaglandins, Bengt Samuelson their
metabolic pathways, and in John Vane showed that aspirin inhibits
them, a discovery that stimulated worldwide interest. In 1982, Vane shared the
Nobel Prize in physiology and medicine with Bergstrom and Samuelson.
Prostaglandins
are synthesized, among others, by coral, algae, sponges, fungi, shellfish,
fish, insects, reptiles, birds, vertebrates, mammals, primates and
humans. Enter, "prostaglandins" in a biomedical database, and
you will find thousands of studies revealing their regulation of our physiology. Databases also contain copious evidence of the role of
prostaglandins in many of our diseases. Prostaglandins are key factors in
lactose intolerance and hay fever, as much as they are they are in depression,
heart attacks, strokes, and cancer.
In 1964, E.W. Horton reported that prostaglandins have powerful effects
on the brain. Inspired by his study, pharmacologists, including my late
colleague David Horrobin, showed that drugs that act on the brain, such
as lithium and antidepressants, inhibit prostaglandins. All of the putative mechanisms of
developing cancer are driven by excessive prostaglandin production. Cancer is
accelerated replication of abnormal cells, and prostaglandins are responsible
for developing abnormal cells, and for cell replication. In 1977 Horrobin showed that prostaglandins
regulate nucleic acids (DNA and RNA). Neglect or suppression of this
study allowed genomics to become the prevailing paradigm, and dominate medical
research.
In his “Against Method” Paul Feyerabend noted that
suppressing a paradigm in preference to one politically favored could
permanently damage society. In
the nineteen-seventies-and-eighties, prostaglandins attracted substantial drug
company investment, one of the companies referring to them as
“Medicine’s New Frontier.” With new technology that
accelerates the production of DNA, venture capitalists, and the U.S patent
office launched biotechnology and genomics, stampeding these companies into
divesting from prostaglandins to buy biotechnology and genomics
companies to secure their patents.
The premier
medical journals have paid scant attention to prostaglandins, publishing many
hundreds of articles in which they are not mentioned. The two prostaglandin
specialty journals focus on high tech research with a narrow focus, rejecting
low tech, clinical articles with broad implications. Medical school deans in
both the US and UK vie for funding, with prostaglandins last on the list rather
than first. Prostaglandins are biomedicine’s true standard with which to
differentiate truth from untruth. Many laboratories continue to publish quality
studies on prostaglandins, but more than enough was known about them thirty
years ago to have warranted a paradigm shift .“Evidence,” now a
buzzword, is often suppressed or hyped to the advantage of pharma, media, and
politicians, both those in Washington and in medical schools. When
genomics was shown to be flawed, “epigenetics” was launched to
search for factors regulating genes, deftly ignoring the fact that
prostaglandins had been shown to be these factors.
Prostaglandins
determine tolerance or intolerance towards everything with which the body comes
into contact, including stem and genetically altered cells. Medical research is
largely based on the premise that DNA and RNA in the cell nucleus, and enzymes
and proteins in the cell, whose structures are defined by DNA, are of
overwhelming importance in disease. While significant, their practical
importance has been exaggerated. Membrane lipids, which modulate the behavior
of these entities, offer far more opportunities for practical therapeutic
interventions.
Trying to
shed light on resistance to, or suppression of, advances is a key theme of the
writings of philosophers and historians of science and medicine. I believe that
the answer may be found in the teachings of Francis Bacon: a lack of ethics,
and a lack of charity. Paul Feyerabend noted that the guardians of paradigm
failures seldom concede to valid newcomers, to the extent that political
intervention might hold the only hope of progress. With global warming and
aging populations, we face alarming increases in infection and cancer rates,
and the importation of tropical infections, with the suppression of
prostaglandins imperiling our ability to manage them. We are amazed at how
easily people lost their senses in signing up for the South Seas bubble, and
the Dutch tulip mania. Unless we act quickly, posterity will view us as ruining
healthcare by abandoning prostaglandins. Julian Lieb, M.D is a retired Yale medical school psychiatry
professor, now specializing in the immunopharmacology of infectious disorders
and cancer. He has authored or coauthored forty- five articles and nine
books.
|